Enbrel Side Effects: Uses, Dosage, and Side Effects — A Clinical Overview

Enbrel side effects most often include injection-site reactions and upper respiratory infections, but the medicine can also increase the risk of serious infections and other important complications. Enbrel is a prescription biologic medicine, and its benefits and risks should be reviewed regularly with the clinician who prescribes it.

Enbrel Side Effects at a Glance

Enbrel side effects are often mild and manageable, with injection-site redness, itching, swelling, pain, or bruising among the most commonly reported effects. Colds, sinus infections, and other upper respiratory infections can also occur. However, because Enbrel affects immune system signaling, it may make some infections harder for the body to control.

Enbrel is the brand name for etanercept, a biologic medicine called a tumor necrosis factor (TNF) blocker. TNF is a protein involved in inflammation. Blocking TNF can reduce pain, swelling, skin symptoms, and joint damage in certain inflammatory diseases, but it also means that treatment requires attention to infection prevention, screening, and follow-up.

A person should not stop, restart, or change Enbrel treatment without discussing it with the prescribing clinician. The appropriate treatment plan depends on the condition being treated, other medicines, past infections, vaccination status, and individual health factors.

What Enbrel Is Used For

Enbrel is approved for several immune-mediated inflammatory conditions. In adults, these include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis with objective signs of inflammation, and chronic moderate-to-severe plaque psoriasis in people who may benefit from systemic treatment or phototherapy.

It is also used in children aged 2 years and older with active polyarticular juvenile idiopathic arthritis, and in children aged 4 years and older with chronic moderate-to-severe plaque psoriasis when systemic therapy or phototherapy may be appropriate. A pediatric specialist should supervise treatment in children.

In some conditions, Enbrel may be used alone. In others, it may be prescribed with medicines such as methotrexate when a clinician considers the combination appropriate. For example, people with inflammatory joint symptoms related to psoriatic arthritis may need a treatment plan that addresses both joint inflammation and skin disease.

Enbrel is not a pain reliever for occasional symptoms and is not suitable for every type of arthritis or skin rash. Its use should be based on a clear diagnosis and an individualized assessment of potential benefits and risks.

Common and Less Common Side Effects

The most common Enbrel side effects are reactions where the injection is given. These may include redness, itching, pain, swelling, warmth, or bruising. They often occur during the first month of treatment and commonly become less frequent over time. Rotating injection sites and following the product instructions may help reduce local irritation.

Other relatively common effects include upper respiratory infections, such as a cold or sinus infection. Headache, fever, and rash may also occur. Not every symptom during treatment is caused by Enbrel, but new or persistent symptoms should be discussed with a healthcare professional, especially if they affect daily life or worsen after each dose.

Less common but clinically important possible effects include serious infections, allergic reactions, blood-count changes, new or worsening psoriasis, liver problems, nervous system symptoms resembling demyelinating disease, and autoimmune-type reactions such as lupus-like syndrome. TNF blockers have also been associated with rare reports of certain cancers, particularly lymphoma and other malignancies, although a person’s underlying inflammatory disease and prior treatments can also influence risk.

Patients should tell their clinician about unusual bruising or bleeding, ongoing fever, unexplained weight loss, night sweats, enlarged lymph nodes, marked fatigue, persistent rash, yellowing of the skin or eyes, or new numbness, weakness, visual changes, or balance problems. These symptoms do not necessarily mean a serious reaction is present, but they deserve timely assessment.

Serious Infection Risk and Safety Screening

The most important safety concern with Enbrel is a higher risk of serious infection. Bacterial, viral, fungal, and opportunistic infections have occurred in people taking TNF blockers. Tuberculosis may develop or reactivate, including in people who previously had no symptoms of active tuberculosis. For this reason, clinicians typically evaluate patients for tuberculosis before treatment and monitor for symptoms during therapy.

Before starting Enbrel, the clinician may also ask about repeated infections, diabetes, lung disease, HIV, hepatitis B infection, travel or residence in areas where certain fungal infections are more common, and close contact with people who have tuberculosis. Testing for hepatitis B may be appropriate because hepatitis B can reactivate during immune-modifying treatment.

Enbrel should not be started during an active infection, including a significant localized infection, unless the treating clinician determines otherwise. If a serious infection develops while taking Enbrel, the prescriber may recommend temporarily stopping the medicine while the infection is assessed and treated.

Vaccination planning is also important. In general, live vaccines should be avoided during Enbrel treatment. Non-live vaccines may be suitable, although immune responses can vary. A clinician can advise on vaccines such as influenza, pneumococcal, shingles, COVID-19, and childhood vaccines based on age, medical history, and local recommendations.

Dosage, Injections, and Medicine Interactions

Enbrel is given as an injection under the skin. Official dosing schedules vary by age, body weight in some pediatric settings, and the condition being treated. The prescribed product format and schedule should be followed exactly, and dosage questions should be directed to the prescribing clinician or pharmacist rather than adjusted independently.

Patients who use Enbrel at home should receive training on storage, preparation, injection technique, and safe disposal of needles or pens. The medicine should not be injected into skin that is tender, bruised, red, hard, scarred, or affected by psoriasis. If an injection is missed or there is uncertainty about timing, the healthcare team can provide condition-specific advice.

Some medicine combinations may increase the risk of infection or other complications. Enbrel should generally not be used together with anakinra or abatacept because combination treatment may raise the risk of serious infections without providing added benefit. Cyclophosphamide is also generally avoided with Enbrel due to safety concerns.

People should provide a complete medication list, including prescriptions, over-the-counter products, supplements, and vaccines. This is especially important for people taking corticosteroids, other biologic medicines, medicines that suppress immunity, or treatments for chronic infections. A pharmacist or clinician can check for relevant interactions and coordinate care between specialists.

Who May Need Extra Caution

Enbrel is not appropriate for everyone. It is contraindicated in people with sepsis, and it should be used cautiously in those with a current or recurring infection. People with poorly controlled diabetes, chronic lung disease, immune deficiency, or a history of serious infections may need particularly careful risk assessment.

People with heart failure should discuss Enbrel carefully with their clinician. TNF-blocking medicines have been associated with new or worsening heart failure in some patients. New shortness of breath, swelling in the feet or ankles, sudden weight gain, or reduced ability to exercise should be reported promptly.

Extra caution may also be needed for those with a history of demyelinating disorders, such as multiple sclerosis or optic neuritis; blood disorders; hepatitis B; or previous cancer. The decision to use Enbrel in these circumstances is individualized and may involve input from rheumatology, dermatology, gastroenterology, neurology, cardiology, or oncology specialists.

Pregnancy and breastfeeding should be discussed with the clinician before treatment is started, continued, or stopped. The safest plan depends on the underlying inflammatory condition, disease control, other medicines, and the stage of pregnancy. A specialist can help balance the importance of controlling inflammation with medication safety considerations.

When to Seek Medical Care

Urgent medical advice is appropriate for signs of a serious infection. These include fever or chills, persistent cough, shortness of breath, chest pain, coughing up blood, painful urination, severe abdominal pain, a painful skin area that is red or swollen, or a wound that does not heal. People should also contact their prescriber if they have close exposure to tuberculosis or develop symptoms after travel that could suggest an infection.

Emergency care is needed for symptoms of a severe allergic reaction, such as difficulty breathing, swelling of the face, lips, tongue, or throat, widespread hives, fainting, or severe dizziness. Sudden weakness, confusion, severe visual symptoms, or symptoms suggesting a stroke also require emergency assessment.

Less urgent but important reasons to contact the healthcare team include new or worsening rash, persistent fatigue, unusual bruising, recurrent infections, yellow skin or eyes, swollen lymph nodes, numbness or tingling, or worsening joint, skin, or bowel symptoms. Regular follow-up helps clinicians monitor treatment response and possible side effects.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support international patients who need assessment and treatment planning for inflammatory conditions requiring biologic medicines. Care decisions should always be made with a qualified clinician who knows the patient’s complete medical history.

Frequently asked questions

What are the most common Enbrel side effects?

The most common side effects are injection-site reactions, including redness, itching, pain, swelling, or bruising. Upper respiratory infections, such as colds and sinus infections, may also occur. Patients should mention persistent or troublesome symptoms to their prescribing clinician.

Can Enbrel cause serious infections?

Yes. Enbrel can increase the risk of serious bacterial, viral, fungal, and opportunistic infections because it modifies immune activity. Tuberculosis can also reactivate, which is why screening is generally performed before treatment begins.

Should Enbrel be stopped when a person has a cold or infection?

A person should contact the prescribing clinician for advice rather than deciding alone. Mild symptoms may not always require a treatment change, but significant infections, fever, or worsening symptoms need prompt assessment. Enbrel may be paused if a serious infection is suspected or confirmed.

Can a person receive vaccines while taking Enbrel?

Many non-live vaccines may be given during Enbrel treatment, but the timing should be reviewed with a healthcare professional. Live vaccines are generally avoided while taking Enbrel. Vaccine recommendations depend on age, infection risks, previous vaccines, and local guidance.

Which medicines should not be taken with Enbrel?

Enbrel is generally not used with anakinra or abatacept because these combinations can increase infection risk. It is also generally avoided with cyclophosphamide. A clinician or pharmacist should review all medicines, supplements, and vaccines before starting treatment.

Does Enbrel increase cancer risk?

Malignancies, including lymphoma and skin cancers, have been reported in people receiving TNF blockers. The actual risk for an individual is influenced by the underlying disease, other treatments, age, and medical history. Patients should discuss personal cancer history and appropriate screening with their clinician.

References

• U.S. Food and Drug Administration
• National Library of Medicine
• American College of Rheumatology
• National Psoriasis Foundation
• Centers for Disease Control and Prevention

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.